Almost half of the most commonly used medications to treat mental illness in South Africa were out of stock in August, and many have been in short supply since March. Now, experts warn that amid the COVID-19 outbreak, the nation could see a “shadow epidemic” of psychiatric illness. Laura Lopez Gonzalez investigates.
Initial results from an antibody survey conducted in the Cape Town Metro indicate that of 2 700 pregnant women and people living with HIV making use of the public healthcare system, 40% have previously been infected with SARS-CoV-2. Adele Baleta has the details.
South Africa does not currently register medical devices. So what does it mean when the regulator announces that a new COVID-19 test or ventilator has been authorised? Catherine Tomlinson unpacks what is required to market a medical device in South Africa.
Two years after it was announced that the ARV dolutegravir would become part of standard first line HIV treatment in South Africa, it is finally reaching significant numbers of people. But new research about a worrying side-effect, weight gain (particularly in women), has muddied its otherwise stellar reputation.
With abortion services now available through telemedicine and the increasing practice of self-managed abortion, Marion Stevens asks if abortion law still has any relevance given these practices.
South Africa is consolidating its place in the race for a COVID-19 vaccine with its participation starting from next month in two new international trials of vaccine candidates. Adele Baleta reports.
A recent announcement about a vaginal ring to prevent HIV has AIDS activists and women’s sexual and reproductive health advocates excited. But where would this ring fit in South Africa’s HIV prevention programme? Amy Green investigates.
Over the last decade the treatment of hepatitis C, a virus that can infect and damage the liver, has been revolutionised by a new class of medicines called direct acting antivirals. Catherine Tomlinson investigates the regulatory obstacles that are limiting access to these breakthrough medicines in South Africa.
Recently the South African Health Products Regulatory Authority was criticised for not approving laboratory-based SARS-CoV-2 antibody tests. Spotlight Editor Marcus Low argues that despite the regulator’s capacity constraints, its flexible conservatism is something to be grateful for.
The South African Health Products Regulatory Authority has approved its first COVID-19 antibody test amid criticism that it is too slow and too cautious in approving applications for the registration of such tests.
The spraying of sanitisers on people in special tunnels or booths in order to combat COVID-19 has been condemned by scientists and government as unnecessary and potentially harmful. Some manufacturers nevertheless continue to market these products. Elna Schütz investigates.
The Pretoria High Court this week heard a challenge to the regulation of complementary medicine in South Africa. Tendai Mafuma and Julia Chaskalson explains why the case is important and why SECTION27 and the TAC got involved.